Zygomycosis in immunocompromised non-haematological patients

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 3, Issue 1, 2011, Pages

  Petrikkos, George ^a   Drogari Apiranthitou, Miranda ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84913614179     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2011.012     Document Type: Article

References (146)

1. Ribes J.A., Vanover-Sams C. L. and Baker D. J. Zygomycetes in Human Disease. Clinical Microbiology Reviews, April 2000, p. 236-301, Vol. 13, No. 2.
2. De Hoog, J. Guarro, J. Gené and M.J. Figueras, Atlas of clinical fungi (2nd ed.), Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, Utrecht 2000. Pp. 81-123.
3. Drouhet E, Ravisse PCurr Top Med Mycol. Entomophthoromycosis. 1993;5:215-45.
4. Dworzack, D. L., A. S. Pollok, G. R. Hodges, W. C. Barnes, L. Ajello and A. Padhye. 1978. Zygomycosis of the maxillary sinus and palate caused by Basidiobolus haptosporus. Arch. Intern. Med. 138:1274-1276. doi:10.1001/archinte.138.8.1274 PMid:567045
5. Roy, A. D., and H. M. Cameroon. 1972. Rhinophycomycosis entomophthorae occurring in a chimpanzee in the wild in East Africa. Am. J. Trop. Med. Hyg. 21:234-237. PMid:5062225
6. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 1;41(5):634-53. Epub 2005 Jul 29. doi:10.1086/432579 PMid:16080086
7. Ramos A, Cuervas-Mons V, Noblejas A, Baños I, Duran P, Marcos R, Sánchez-Turrión V, Jiménez M, Arellano B, Corbacho C, Sánchez-Romero I. Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. Transplant Proc. 2009 Jun;41(5):1972-5. doi:10.1016/j.transproceed.2009.01.077 PMid:19545771
8. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18(3):556-69 doi:10.1128/CMR.18.3.556-569.2005 PMid:16020690 PMCid:1195964
9. Prabhu RM, Patel R Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment Clin Microbiol Infect 2004 Mar;10 Suppl 1:31-47. doi:10.1111/j.1470-9465.2004.00843.x PMid:14748801
10. Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006; 44 (4): 335-42. doi:10.1080/13693780500464930 PMid:16772227
11. Platauf, A. P. (1885). Mycosis mucorina. Virchows Archiv: An International Journal of Pathology 102, 543-64. doi:10.1007/BF01932420
12. Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009 Sep;15(9):1395-401. doi:10.3201/eid1509.090334 PMid:19788806 PMCid:2819884
13. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, Candoni A, Nosari A, Riva M, Cattaneo C, Rossini F, Fianchi L, Caira M, Sanguinetti M, Gesu GP, Lombardi G, Vianelli N, Stanzani M, Mirone E, Pinsi G, Facchetti F, Manca N, Savi L, Mettimano M, Selva V, Caserta I, Scarpellini P, Morace G, D'Arminio Monforte A, Grossi P, Giudici D, Tortorano AM, Bonini A, Ricci L, Picardi M, Rossano F, Fanci R, Pecile P, Fumagalli L, Ferrari L, Capecchi PL, Romano C, Busca A, Barbui A, Garzia M, Minniti RR, Farina G, Montagna MT, Bruno F, Morelli O, Chierichini A, Placanica PM, Castagnola E, Bandettini R, Giordano S, Monastero R, Tosti ME, Rossi MR, Spedini P, Piane R, Nucci M, Pallavicini F, Bassetti M, Cristini F, LA Sorda M, Viviani M. J Chemother. 2009 Jun;21(3):322-9. PMid:19567354
14. Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K. Increasing incidence of mucormycosis in university hospital, Belgium. Emerg Infect Dis. 2010 Sep;16(9):1456-8. doi:10.3201/eid1609.100276 PMid:20735932
15. Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Flörl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother. 2010 Feb;65(2):296-302. doi:10.1093/jac/dkp430 PMid:20008047
16. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; for the European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011 Jan 2. doi: 10.1111/j.1469-0691.2010.03456.x. [Epub ahead of print] doi:10.1111/j.1469-0691.2010.03456.x PMid:21199154
17. Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, Varma SC, Singhi S, Bhansali A, Sakhuja V. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J. 2009 Nov;85(1009):573-81. doi:10.1136/pgmj.2008.076463 PMid:19892892
18. Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D'Souza O (2003) Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 51:231-236 PMid:14601848
19. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906-1912. doi:10.1056/NEJM199912163412507 PMid:10601511
20. M. Chayakulkeeree. M. A. Ghannoum. J. R. Perfect. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006; 25(4):215-29. doi:10.1007/s10096-006-0107-1 PMid:6756909
21. Sugar AM (2005) Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Elsevier Churchill Livingstone, Philadelphia, pp 2973-2984.
22. Gonzalez CE, Rinaldi MG, Sugar AM (2002) Zygomycosis. Infect Dis Clin North Am 16:895-914. doi:10.1016/S0891-5520(02)00037-5
23. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA (2004). Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 17:517-525. doi:10.1097/00001432-200412000-00003 PMid:15640705
24. Helderman JH, Cooper HS, Mann J (1974) Chronic phycomycosis in a controlled diabetic. Ann Intern Med 80:419. PMid:4816193
25. Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P, Chakarbarti A, Dash RJ (2004) Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 80:670-674. doi:10.1136/pgmj.2003.016030 PMid:15537854 PMCid:1743145
26. Bagdade, J. D. 1976. Phagocytic and microbiocidal function in diabetes mellitus. Acta Endocrinol. 83:27-33.
27. Bybee, J. D., and D. E. Rogers. 1964. The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J. Lab. Clin. Med. 64:1-13. PMid:14192564
28. Mowat, A. G., and J. Baum. 1971. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N. Engl. J. Med. 284:621-627. doi:10.1056/NEJM197103252841201 PMid:5545603
29. Sheldon, W. H., and H. Bauer. 1959. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J. Exp. Med. 110:845-852. doi:10.1084/jem.110.6.845 PMid:14445772 PMCid:2137039
30. Gregory, J. E., A. Golden, and W. Haymaker. 1943. Mucormycosis of the central nervous system: a report of three cases. Bull. Johns Hopkins Hosp.73:405-419.
31. Ludvigsson J. Why diabetes incidence increases--a unifying theory. Ann N Y Acad Sci. 2006 Oct;1079:374-82. doi:10.1196/annals.1375.058 PMid:17130582
32. Kontoyiannis DP. Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Clin Infect Dis. 2007 Apr 15;44(8):1089-90. doi:10.1086/512817 PMid:17366455
33. Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 2006 Jan;50(1):96-103. doi:10.1128/AAC.50.1.96-103.2006 PMid:16377673 PMCid:1346800
34. Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008 Aug 1;47(3):364-71. doi:10.1086/589857 PMid:18558882 PMCid:2793535
35. Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P, Panda N, Verma SC, Sakhuja V. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006 Jun;44(4):335-42. doi:10.1080/13693780500464930 PMid:16772227 http://www.who.int/mediacentre/factsheets/fs312/en/index.html
36. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007 Jun;45(4):321-46. doi:10.1080/13693780701218689 PMid:17510856
37. Gupta KL, Radotra BD, Sakhuja V, Banerjee AK, Chugh KS (1989) Mucormycosis in patients with renal failure. Ren Fail 11:195-199 doi:10.3109/08860228909054931 PMid:2485482
38. Espinoza CG, Halkias DG (1983) Pulmonary mucormycosis as a complication of chronic salicylate poisoning. Am J Clin Pathol 80:508-511 PMid:6624716
39. Lewis LL, Hawkins HK, Edwards MS (1990) Disseminated mucormycosis in an infant with methylmalonicaciduria. Pediatr Infect Dis J 9:851-854. doi:10.1097/00006454-199011000-00016
40. Bullen J J: The significance of iron in infection. Rev Infect Dis 1981; 3: 1127-1138. doi:10.1093/clinids/3.6.1127
41. Payne SM: Iron and virulence in the family Enterobacteriaceae. CRC Crit Rev Microbio] 1988; 16: 81-111. doi:10.3109/10408418809104468 PMid:3067977
42. Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008 Dec;21(6):620-5. doi:10.1097/QCO.0b013e3283165fd1 PMid:18978530 PMCid:2773686
43. Artis WM, Fountain JA, Delcher HK, Jones HE: A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982; 31: 1109-1114. doi:10.2337/diabetes.31.12.1109 PMid:6816646
44. Daly AL, Velazquez LA, Bradley SF, Kauffman CA. Mucormycosis: association with deferoxamine therapy. Am J Med. 1989 Oct;87(4):468-71.doi:10.1016/S0002-9343(89)80836-8
45. Gluskin, M., M. P. Solomon, B. Gold, M. L. Corrado, and J. Berger. 1979. Mucormycosis slough of nasal floor and palate in the anephric patient. J. Am. Dent. Assoc. 98:224-227. PMid:284067
46. Boelaert JR, Fenves AZ, Coburn JW. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis. 1991 Dec;18(6):660-7. PMid:1962650
47. Boelaert, J. R., J. Van Cutsem, M. De Locht, Y. J. Schneider, and R. R. Crichton. 1994. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 45:667-671. doi:10.1038/ki.1994.89 PMid:8196268
48. Sugar AM (1992) Mucormycosis. Clin Infect Dis 14(Suppl 1): S126-S129.
49. McNab AA, McKelvie P (1997) Iron overload is a risk factor for zygomycosis. Arch Ophthalmol 115:919-921. PMid:9230837
50. Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GE, Vandenberghe P, Boogaerts MA (1999) Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 24:307-312. doi:10.1038/sj.bmt.1701885 PMid:10455371
51. Symeonidis AS. The role of iron and iron chelators in zygomycosis. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:26-32. doi:10.1111/j.1469-0691.2009.02976.x PMid:19754753
52. Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006 Oct;6(10):2365-74. doi:10.1111/j.1600-6143.2006.01496.x PMid:16925570
53. Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Flörl C, Johnson L, Dubberke ER, Barron MA, Lortholary O. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009 Sep 15;200(6):1002-11. doi:10.1086/605445 PMid:19659439
54. Sun HY, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Florl C, Johnson L, Dubberke ER, Barron MA, Lortholary O, Singh N; Zygomycosis Transplant Study Group. Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant. 2009 Sep;9(9):2166-71. doi:10.1111/j.1600-6143.2009.02754.x PMid:19681829
55. Antinori S, Nebuloni M, Magni C, Fasan M, Adorni F, Viola A, Corbellino M, Galli M, Vago G, Parravicini C, Ridolfo AL. Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol. 2009 Aug;132(2):221-7. doi:10.1309/AJCPRAAE8LZ7DTNE PMid:19605816
56. Moraru RA, Grossman ME. Palatal necrosis in an AIDS patient: a case of mucormycosis. Cutis. 2000 Jul;66(1):15-8. Review. PMid:10916685
57. Van den Saffele JK, Boelaert JR. Zygomycosis in HIV-positive patients: a review of the literature. Mycoses. 1996 Mar-Apr;39(3-4):77-84. doi:10.1111/j.1439-0507.1996.tb00106.x PMid:8766998
58. Nagy-Agren SE, Chu P, Smith GJ, Waskin HA, Altice FL. Zygomycosis (mucormycosis) and HIV infection: report of three cases and review. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 1;10(4):441-9. doi:10.1097/00042560-199512000-00007 PMid:7583440
59. Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S. Zygomycosis and HIV infection. J Am Acad Dermatol. 1994 May;30(5 Pt 2):904-8. doi:10.1016/S0190-9622(94)70110-5
60. Blatt SP, Lucey DR, DeHoff D, Zellmer RB (1991). Rhinocerebral zygomycosis in a patient with AIDS. J Infect Dis 164:215-216. PMid:2056212
61. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis. 1994 Dec;19(6):1133-7. PMid:7888545
62. Merchant S, Reichman R, Koval CE. Rhinocerebral zygomycosis in an HIV-infected man during therapy with an investigational CCR5 inhibitor. AIDS. 2007 Jul 31;21(12):1666-9. doi:10.1097/QAD.0b013e328274257b PMid:17630574
63. Parra-Ruiz J, Peña-Monje A, Tomas-Jimenez C, Antelo-Lorenzo R, Escobar-Lara T, Hernández-Quero J. Septic arthritis due to Absidia corymbifera in a patient with HIV-1 infection. Infection. 2008 Jun;36(3):279-81. Epub 2007 Dec 14. doi:10.1007/s15010-007-6297-3 PMid:18084717
64. Bongiovanni M, Ranieri R, Ferrari D, Codecà C, Tartaro T, Uziel L. Prolonged survival of an HIV-infected subject with severe lymphoproliferative disease and rhinocerebral mucormycosis. J Antimicrob Chemother. 2007 Jul;60(1):192-3. doi:10.1093/jac/dkm148 PMid:17496057
65. Samant JS, Namgoong SH, Parveen T, Katner HP. Cytomegalovirus vasculitis and mucormycosis coinfection in late-stage HIV/AIDS. Am J Med Sci. 2007 Feb;333(2):122-4. doi:10.1097/00000441-200702000-00011 PMid:17301593
66. Boumis E, Chinello P, Conte A, Noto P, Cicalini S, Grillo LR, Petrosillo N. Rhino-orbital zygomycosis secondary to diabetic ketoacidosis in an HIV-positive patient: case report and literature review. AIDS. 2006 Jan 2;20(1):136-8. doi:10.1097/01.aids.0000198079.32207.5a PMid:16327338
67. Samanta TK, Biswas J, Gopal L, Kumarasamy N, Solomon S. Panophthalmitis due to rhizopus in an AIDS patient: a clinicopathological study. Indian J Ophthalmol. 2001 Mar;49(1):49-51. PMid:15887716
68. Virally ML, Riveline JP, Virally J, Chevojon P, Regnard JF, Belmekki A, Devidas A. Pulmonary mucormycosis in a diabetic patient with HIV. Diabetes Care. 2002 Nov;25(11):2105. doi:10.2337/diacare.25.11.2105 PMid:12401766
69. Guardia JA, Bourgoignie J, Diego J. Renal mucormycosis in the HIV patient. Am J Kidney Dis. 2000 May;35(5):E24. doi:10.1016/S0272-6386(00)70289-7
70. Carvalhal GF, Machado MG, Pompeo A, Saldanha L, Sabbaga E, Arap S. Mucormycosis presenting as a renal mass in a patient with the human immunodeficiency virus. J Urol. 1997 Dec;158(6):2230-1. doi:10.1016/S0022-5347(01)68208-9
71. Blázquez R, Pinedo A, Cosín J, Miralles P, Lacruz C, Bouza E. Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user. Eur J Clin Microbiol Infect Dis. 1996 Jul;15(7):598-9. doi:10.1007/BF01709370 PMid:6756909
72. Santos J, Espigado P, Romero C, Andreu J, Rivero A, Pineda JA. Isolated renal mucormycosis in two AIDS patients. Eur J Clin Microbiol Infect Dis. 1994 May;13(5):430-2. doi:10.1007/BF01972004 PMid:6756909
73. [No authors listed] Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 52-1990. A 31-year-old HIV-seropositive women with a cerebral lesion seven years after treatment of carcinoma of the cervix. N Engl J Med. 1990 Dec 27;323(26):1823-33. doi:10.1056/NEJM199012273232608 PMid:2247121
74. Smith AG, Bustamante CI, Gilmor GD. Zygomycosis (absidiomycosis) in an AIDS patient. Absidiomycosis in AIDS. Mycopathologia. 1989 Jan;105(1):7-10. doi:10.1007/BF00443823 PMid:2739694
75. Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, Gilliet M, Halder G, Kontoyiannis DP. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9367-72. doi:10.1073/pnas.0709578105 PMid:18583479 PMCid:2453716
76. McNulty, J. S. 1982. Rhinocerebral mucormycosis: predisposing factors. Laryngoscope 92:1140-1143. PMid:7132514
77. Mok CC, Que TL, Tsui EY, Lam WY. Mucormycosis in systemic lupus erythematosus. Semin Arthritis Rheum. 2003 Oct;33(2):115-24. doi:10.1016/S0049-0172(03)00081-7
78. Arce-Salinas CA, Pérez-Silva E. Mucormycosis complications in systemic lupus erythematosus. Lupus. 2010;19(8):985-8. doi:10.1177/0961203309357574 PMid:20064915
79. Shenoi S, Emery HM. Successful treatment of invasive gastric mucormycosis in a child with systemic lupus erythematosus. Lupus. 2010 Apr;19(5):646-9. doi:10.1177/0961203309349117 PMid:19939907
80. Peel T, Daffy J, Thursky K, Stanley P, Buising K. Posaconazole as first line treatment for disseminated zygomycosis. Mycoses. 2008 Nov;51(6):542-5. doi:10.1111/j.1439-0507.2008.01499.x PMid:18422921
81. Yu J, Li RY. Primary renal zygomycosis due to Rhizopus oryzae. Med Mycol. 2006 Aug;44(5):461-6. doi:10.1080/13693780500338951 PMid:16882613
82. Fujimoto A, Nagao K, Tanaka K, Yamagami J, Udagawa SI, Sugiura M. The first case of cutaneous mucormycosis caused by Rhizopus azygosporus. Br J Dermatol. 2005 Aug;153(2):428-30. doi:10.1111/j.1365-2133.2005.06593.x PMid:16086761
83. Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth. 2002 Oct;49(8):880-2. doi:10.1007/BF03017426 PMid:12374722
84. Sungkanuparph S, Sathapatayavongs B, Kunachak S, Luxameechanporn T, Cheewaruangroj W. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases. J Med Assoc Thai. 2001 Apr;84(4):593-601. PMid:11460976
85. Liu MF, Chen FF, Hsiue TR, Liu CC. Disseminated zygomycosis simulating cerebrovascular disease and pulmonary alveolar haemorrhage in a patient with systemic lupus erythematosus. Clin Rheumatol. 2000;19(4):311-4. doi:10.1007/s100670070052 PMid:10941815
86. Hosseini M, Lee J. Gastrointestinal mucormycosis mimicking ischemic colitis in a patient with systemic lupus erythematosus. Am J Gastroenterol. 1998 Aug;93(8):1360-2.doi:10.1111/j.1572-0241.1998.00417.x PMid:9707066
87. Dickinson M, Kalayanamit T, Yang CA, Pomper GJ, Franco-Webb C, Rodman D Cutaneous zygomycosis (mucormycosis) complicating endotracheal intubation: diagnosis and successful treatment. Chest. 1998 Jul;114(1):340-2. doi:10.1378/chest.114.1.340 PMid:9674495
88. Fingerote RJ, Seigel S, Atkinson MH, Lewkonia RM. Disseminated zygomycosis associated with systemic lupus erythematosus. J Rheumatol. 1990 Dec;17(12):1692-4. PMid:2084248
89. Bloxham CA, Carr S, Ryan DW, Kesteven PJ, Bexton RS, Griffiths ID, Richards J. Disseminated zygomycosis and systemic lupus erythematosus. Intensive Care Med. 1990;16(3):201-7 doi:10.1007/BF01724803 PMid:2351780
90. Wong KL, Tai YT, Loke SL, Woo EK, Wong WS, Chan MK, Ma JT. Disseminated zygomycosis masquerading as cerebral lupus erythematosus. Am J Clin Pathol. 1986 Oct;86(4):546-9. PMid:3766468
91. Yu J, Li RY. Primary renal zygomycosis due to Rhizopus oryzae. Med Mycol. 2006 Aug;44(5):461-6. doi:10.1080/13693780500338951 PMid:16882613
92. Arce-Salinas CA, Pérez-Silva E. Mucormycosis complications in systemic lupus erythematosus. Lupus. 2010;19(8):985-8. doi:10.1177/0961203309357574 PMid:20064915
93. Nogueira EL, Ind PW, Friedland JS, Salama AD. Mucormycosis may mimic disease relapse in Wegener's granulomatosis. J Rheumatol. 2010 Jun;37(6):1364-5. doi:10.3899/jrheum.091423 PMid:20516047
94. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:41-5. doi:10.1111/j.1469-0691.2009.02979.x PMid:19754756
95. Arney, G. K., E. Pearsons, and A. B. Sutherland. 1960. Burn stress diabetes. Ann. Surg. 152:77-90. doi:10.1097/00000658-196007000-00012 PMid:13794351 PMCid:1613595
96. Rabin, E. R., G. D. Lundberg, and E. T. Mitchell. 1961. Mucormycosis in severely burned patients. N. Engl. J. Med. 264:1286-1289. doi:10.1056/NEJM196106222642504 PMid:13738817
97. Chander J, Kaur J, Attri A, Mohan H. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J Med Res. 2010 Jun;131:765-70. PMid:20571164
98. Lumbang WA, Caufield BA. Vesicular eruption on the arm of an infant. Dermatol Online J. 2010 May 15;16(5):13. PMid:20492830
99. Woo PC, Lau SK, Ngan AH, Tung ET, Leung SY, To KK, Cheng VC, Yuen KY. Lichtheimia hongkongensis sp. nov., a novel Lichtheimia spp. associated with rhinocerebral, gastrointestinal, and cutaneous mucormycosis. Diagn Microbiol Infect Dis. 2010 Mar;66(3):274-84. doi:10.1016/j.diagmicrobio.2009.10.009 PMid:20159375
100. Tilak R, Raina P, Gupta SK, Tilak V, Prakash P, Gulati AK. Cutaneous zygomycosis: a possible postoperative complication in immunocompetent individuals. Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):596-9. doi:10.4103/0378-6323.57722 PMid:19915241
101. Stewardson AJ, Holmes NE, Ellis DH, Howden BP. Cutaneous zygomycosis caused by Saksenaea vasiformis following waterrelated wound in a 24-year-old immunocompetent woman. Mycoses. 2009 Nov;52(6):547-9. doi:10.1111/j.1439-0507.2008.01648.x PMid:19682315
102. Lu XL, Liu ZH, Shen YN, She XD, Lu GX, Zhan P, Fu MH, Zhang XL, Ge YP, Liu WD. Primary cutaneous zygomycosis caused by rhizomucor variabilis: a new endemic zygomycosis? A case report and review of 6 cases reported from China. Clin Infect Dis. 2009 Aug 1;49(3):e39-43. doi:10.1086/600817 PMid:19566442
103. Zhao Y, Zhang Q, Li L, Zhu J, Kang K, Chen L. Primary cutaneous mucormycosis caused by Rhizomucor variabilis in an immunocompetent patient. Mycopathologia. 2009 Nov;168(5):243-7. doi:10.1007/s11046-009-9219-3 PMid:19562506
104. Saravia-Flores M, Guaran DM, Argueta V. Mycoses. Invasive cutaneous infection caused by Apophysomyces elegans associated with a spider bite. 2010 May;53(3):259-61.
105. Piazza RC, Thomas WL, Stawski WS, Ford RD. Mucormycosis of the face. J Burn Care Res. 2009 May-Jun;30(3):520-3. doi:10.1097/BCR.0b013e3181a28d2f
106. Almaslamani M, Taj-Aldeen SJ, Garcia-Hermoso D, Dannaoui E, Alsoub H, Alkhal A. An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections. Med Mycol. 2009;47(5):532-8 doi:10.1080/13693780802595746 PMid:19184768
107. Chew HH, Abuzeid A, Singh D, Tai CC. Surgical wound mucormycosis necessitating hand amputation: a case report. J Orthop Surg (Hong Kong). 2008 Aug;16(2):267-9.
108. Chen CK, Wan SH, Kou SK. A rare cutaneous fungal infection complicating bacterial necrotising fasciitis. Hong Kong Med J. 2008 Aug;14(4):314-6. PMid:18685166
109. Lechevalier P, Hermoso DG, Carol A, Bonacorsi S, Ferkdadji L, Fitoussi F, Lortholary O, Bourrillon A, Faye A, Dannaoui E, Angoulvant F. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol. 2008 Sep;46(9):3169-72. doi:10.1128/JCM.00052-08 PMid:18632909 PMCid:2546755
110. Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:55-9. doi:10.1111/j.1469-0691.2009.02982.x PMid:19754759
111. Lass-Flörl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 2007;45(7):e101-4. doi:10.1086/521245 PMid:17806041
112. Greenberg RN, Scott LJ, Vaughn HH, et al. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004; 17(6):517-25. doi:10.1097/00001432-200412000-00003 PMid:15640705
113. Chander J, Textbook of Medical Mycology; New Delhi :Mehta Publishers;2008.
114. Lass-Flörl C. Zygomycosis: conventional laboratory diagnosis. 2009 Oct;15 Suppl 5:60-5.
115. Kurukularatne C, Garcia-Diaz J, Kemmerly S, Reed D, et al. Beyond Rhizopus and Mucor: Hurricane Katrina stirs up Synephalastrum in New Orleans. Presented at Focus on Fungal Infections 16. Las Vegas, March 8-10, 2006.
116. Dannaoui E. Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis. Clin Microb Infect. 2009; 15 (Suppl. 5): 66-70.
117. Bialek R, Konrad F, Kern J, et al. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 2005;58(11): 1180-4.
118. Kobayashi M, Togitani K, Machida H, et al. Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by Cunninghamella bertholletiae. Respirology 2004; 9(3):397-401.
119. Rickerts V, Just-Nubling G, Konrad F, et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 2006;25(1):8-13.
120. Rickerts V, Mousset S, Lambrecht E, Tintelnot K, Schwerdtfeger R, Presterl E, et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 2007 15;44(8):1078-83.
121. Dannaoui E, Schwarz P, Slany M, Loeffler J, Jorde AT, Cuenca-Estrella M, et al. Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation J Clin Microbiol, 2010; 48: 2043-2046.
122. Prabhu R. M. and Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004; 10 (Suppl. 1): 31-7
123. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47:503-9.
124. Herbrecht R, Letscher-Bru V, Bowden RA et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001; 20: 460-6.
125. Ma B, Seymour JF, Januszewicz H, Slavin MA. Cure of pulmonary Rhizomucor pusillus infection in a patient with hairycell leukemia. Role of liposomal amphotericin B and GM-CSF. Leuk Lymphoma 2001; 42: 1393-9.
126. Roy V, Ali LI, Carter TH, Selby GB. Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versushost disease. J Infect 2000; 41: 273-5.
127. Larkin JA, Montero JA. Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 2003; 20: 201-6.
128. Bigby TD, Serota ML, Tierney LM Jr, Matthay MA. Clinical spectrum of pulmonary mucormycosis. Chest 1986; 89: 435-9.
129. Spellberg B, Walsh T, Kontoyiannis DP, et al.: Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009, 48:1743-1751
130. Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006 Jan;50(1):126-33.
131. van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006 Apr 1;42(7):e61-5.
132. Gomez-Lopez A, Cuenca-Estrella M, Monzon A, Rodriguez-Tudela JL. In vitro susceptibilities of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole, and voriconazole. J Antimicrob Chemother 2001; 48: 919-21.
133. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003; 36: 1445-57.
134. Alastruey-Izquierdo A, Castelli MV, Cuesta I, Zaragoza O, Monzón A, Mellado E, Rodríguez-Tudela JL. In vitro activity of antifungals against Zygomycetes. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:71-6. doi:10.1111/j.1469-0691.2009.02984.x PMid:19754762
135. Eisen DP, Robson J. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis. Mycoses 2004; 47(3-4):159-162. doi:10.1111/j.1439-0507.2004.00959.x PMid:15078434
136. Liao WQ, Yao ZR, Li ZQ, Xu H, Zhao J. Pyoderma gangrenosum caused by Rhizopus arrhizus. Mycoses 1995; 38(1-2):75-77. doi:10.1111/j.1439-0507.1995.tb00011.x PMid:7637685
137. Parthiban K, Gnanaguruvelan S, Janaki C, Sentamilselvi G, Boopalraj JM. Rhinocerebral zygomycosis. Mycoses 1998; 41(1-2):51-53. doi:10.1111/j.1439-0507.1998.tb00376.x PMid:9610134
138. Zhao Y, Zhang Q, Li L, Zhu J, Kang K, Chen L. Primary cutaneous mucormycosis caused by Rhizomucor variabilis in an immunocompetent patient. Mycopathologia 2009.
139. Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JE, Jr. et al. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother 2005; 49(2):721-727. doi:10.1128/AAC.49.2.721-727.2005 PMid:15673756 PMCid:547300
140. Garey KW, Pendland SL, Huynh VT, Bunch TH, Jensen GM, Pursell KJ. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature. Pharmacotherapy 2001; 21: 855-60. doi:10.1592/phco.21.9.855.34560 PMid:11444582
141. John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005;11(7):515-517 doi:10.1111/j.1469-0691.2005.01170.x PMid:15966968
142. Liles WC, Huang JE, van Burik JA, Bowden RA, Dale DC. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 1997; 175: 1012-1015. doi:10.1086/513961 PMid:9086172
143. Garcia-Diaz JB, Palau L, Pankey GA. Resolution of rhinocerebral Zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor. Clin Infect Dis 2001; 32: 145-150. doi:10.1086/320767 PMid:11360225
144. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994; 39: 3-22. doi:10.1016/S0039-6257(05)80041-4
145. Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980; 90: 635-48. doi:10.1288/00005537-198004000-00010 PMid:7359982
146. Sun HY, Forrest G, Gupta KL, Aguado JM, Lortholary O, Julia MB, et al. Rhino-orbito-cerebral zygomycosis in solid organ transplant recipients. Transplantation 2010;15(90):85-92. doi:10.1097/TP.0b013e3181dde8fc PMid:20626095